Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,468,253
-$265,939 QoQ
Shares Held
60,974
-1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,102
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AUXIER ASSET MANAGEMENT LLC holds $26,865,861 across 7 Drug Manufacturers - General names. PFE ranks #3 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
69,837 | $17,736,502 | |
| 2 | AMGN |
Amgen Inc
|
8,785 | $3,181,224 | |
| 3 | PFE |
Pfizer Inc
This page
|
60,974 | $1,468,253 | |
| 4 | GSK |
GSK plc
|
27,181 | $1,424,828 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
21,671 | $1,248,683 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,611 | $1,087,913 | |
| 7 | LLY |
ELI LILLY & Co
|
599 | $718,458 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,468,253 | 60,974 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,734,192 | 61,759 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,516,634 | 60,909 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,649,549 | 64,739 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $1,583,817 | 65,339 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,648,569 | 65,058 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,738,457 | 65,528 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $1,975,241 | 68,253 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,924,408 | 68,778 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,901,846 | 68,535 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,059,348 | 71,530 | Shares | Sole | 2024-02-22 | |
| 2023-09-30 | $2,391,557 | 72,100 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $2,653,798 | 72,350 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $2,761,588 | 67,686 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,433,899 | 67,016 | Shares | Sole | 2023-02-17 | |
| 2022-09-30 | $2,969,816 | 67,866 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,640,110 | 69,428 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,635,185 | 70,218 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $4,438,965 | 75,173 | Shares | Sole | 2022-03-01 | |
| 2021-09-30 | $3,258,910 | 75,771 | Shares | Sole | 2021-11-18 | |
| 2021-06-30 | $2,992,646 | 76,421 | Shares | Sole | 2021-08-18 | |
| 2021-03-31 | $2,874,886 | 79,351 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,129,807 | 85,026 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $3,124,121 | 85,126 | Shares | Sole | 2021-03-05 | |
| 2020-06-30 | $2,768,809 | 84,673 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $2,391,464 | 73,268 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||